Treatment of lupus nephritis: A meta-analysis of clinical trials

American Journal of Kidney Diseases

Volumn 29, Issue 2, 1997, Pages 193-199

  Bansal, Vinod K ^a   Beto, Judith A ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lupus nephritis; meta analysis; renal function

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; META ANALYSIS; MORTALITY; ORAL DRUG ADMINISTRATION; STATISTICAL ANALYSIS;

EID: 0030940420     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90029-9     Document Type: Article

References (33)

1. Golbus J, McCune WJ: Lupus nephritis: Classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 20:213-242, 1994
2. Cameron JS: What is the role of long-term cytotoxic agents in the treatment of lupus nephritis? J Nephrol 6:172-176, 1993
3. Donadio JV, Glassock RJ: Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 21:239-250, 1993
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
5. Felson DT, Anderson J: Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. N Engl J Med 311:1528-1533, 1984
6. Cade R, Spooner G, Schiein E, Pickering M, DeQuesada A, Holcomb A, Juncos L, Richard G, Shires D, Levin D, Hackett R, Free J, Hunt R, Fregly M: Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis. Nephron 10:37-56, 1973
7. Donadio JV, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC: Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med 77:829-835, 1972
8. Donadio JV, Holley KE, Wagoner RD, Ferguson RH, McDuffie FC: Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthritis Rheum 17:573-581, 1974
9. Donadio JV, Holley KE, Ferguson RH, Ilstrup DM: Progressive lupus glomerulonephritis. Mayo Clin Proc 51:484-494, 1976
10. Donadio JV, Holley KE, Ferguson RH, Ilstrup DM: Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299:1151-1155, 1978
11. Ginzler E, Diamond H, Guttadauria M, Kaplan D: Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis. Arthritis Rheum 19:693-699, 1976
12. Hahn BH, Kantor OS, Osterland CK: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Ann Intern Med 83:597-605, 1975
13. Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ, Lupus Nephritis Collaborative Study Group: Progression and remission of renal disease in the lupus nephritis collaborative study. Ann Intern Med 116:114-123, 1992
14. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM, Lupus Nephritis Collaborative Study Group: A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373-1379, 1992
15. Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL: Cyclophosphamide in lupus nephritis. Ann Intern Med 75:165-171, 1971
16. Steinberg AD, Decker JL: A double-blind controlled trial comparing cyclophosphamide, azathioprine, and placebo in the treatment of lupus glomerulonephritis. Arthritis Rheum 17:923-937, 1974
17. Decker JL, Klippel JH, Plotz PH, Steinberg AD: Cyclophosphamide or azathioprine in lupus glomerulonephritis. Ann Intern Med 83:606-615, 1975
18. Dinant HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD: Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 96:728-736, 1989
19. Carette S, Klippel JH, Decker JL, Austin HA, Plotz PH, Steinberg AD, Balow JE: Controlled studies of oral immunosuppressive drugs in lupus nephritis. Ann Intern Med 99:1-8, 1983
20. Austin HA, Klippel JH, Balow JE, LeRiche NG, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis. N Engl J Med 314:614-619, 1986
21. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone alone. Arthritis Rheum 34:945-950, 1991
22. Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741-745, 1992
23. Sztejnbok M, Stewart A, Diamond H, Kaplan D: Azathioprine in the treatment of systemic lupus erythematosus: A controlled study. Arthritis Rheum 14:639-645, 1971
24. Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB: Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: A prospective five-year study. Clin Nephrol 42:71-78, 1994
25. Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrignani P, Ciabattoni G, Patrono C: Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N Engl J Med 320:421-425, 1989
26. Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 271:1780-1785, 1994
27. DerSimonian R, Laird NM: Combining evidence in clinical trials. Controlled Clin Trials 7:177-188, 1986
28. Laird NM, Mosteller F: Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6:5-30, 1990
29. Hedges LV, Olkin L: Statistical Methods for Meta-Analysis. San Diego, CA, Academic Press, 1985, pp 153-156
30. Laupacis A, Sackett DL, Roberts RS: The assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728-1733, 1988
31. Austin HA, Boumpas DT, Vaughan EM, Balow JE: Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int 45:544-550, 1994
32. Schwartz NM, Lan MA, Bernstein J, Hill GS, Holley K, Lewis EJ: Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Am J Kidney Dis 21:374-377, 1993
33. Gourley MF, Austin HA, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. Ann Intern Med 125:549-557, 1996